Inventor
HOPKINS BRIAN T
US34 patents
⚠️ This page may combine multiple inventors who share the name “HOPKINS BRIAN T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIOGEN MA INC
18 patentsUS9809577B2Nov 7, 2017
Biaryl inhibitors of Bruton's tyrosine kinase
BIOGEN MA INC12 citations92
US10227341B2Mar 12, 2019
Inhibiting agents for bruton's tyrosine kinase
BIOGEN MA INC8 citations83
US10081619B2Sep 25, 2018
Biaryl inhibitors of bruton's tyrosine kinase
BIOGEN MA INC7 citations83
US9790229B2Oct 17, 2017
Bruton's tyrosine kinase inhibitors
BIOGEN MA INC11 citations83
US10961237B2Mar 30, 2021
Inhibiting agents for Bruton's tyrosine kinase
BIOGEN MA INC4 citations82
US10189829B2Jan 29, 2019
Inhibiting agents for Bruton's tyrosine kinase
BIOGEN MA INC6 citations82
US9944622B2Apr 17, 2018
Pyrimidinyl tyrosine kinase inhibitors
BIOGEN MA INC8 citations82
US10759783B2Sep 1, 2020
Biaryl inhibitors of Bruton'S tyrosine kinase
BIOGEN MA INC3 citations72
US11427577B2Aug 30, 2022
Inhibiting agents for Bruton's tyrosine kinase
BIOGEN MA INC2 citations71
US12391697B2Aug 19, 2025
Condensed bi-heterocycles as inhibiting agents for Bruton's tyrosine kinase
BIOGEN MA INC1 citations63
US11572356B2Feb 7, 2023
Biaryl inhibitors of Bruton's tyrosine kinase
BIOGEN MA INC0 citations62
US11858926B2Jan 2, 2024
Inhibiting agents for bruton's tyrosine kinase
BIOGEN MA INC0 citations61
US10899753B2Jan 26, 2021
Inhibiting agents for Bruton's tyrosine kinase
BIOGEN MA INC1 citations61
US10280169B2May 7, 2019
Biaryl bruton's tyrosine kinase inhibitors
BIOGEN MA INC1 citations56
US12565500B2Mar 3, 2026
Substituted pyrrolo[1,2-b]pyridazines and pyrrolo[2,1-f][1,2,4]triazines as Btk inhibitors
BIOGEN MA INC0 citations51
US12240838B2Mar 4, 2025
Inhibiting agents for Bruton's tyrosine kinase
BIOGEN MA INC0 citations51
US10189817B2Jan 29, 2019
Inhibitors of Bruton's tyrosine kinase
BIOGEN MA INC0 citations49
US12570631B2Mar 10, 2026
Substituted N-(4-(pyrimidin and pyridin-4-yl)benzylcarboxamides and its use for treating disorders responsive to inhibition of Btk
BIOGEN MA INC0 citations45
CASTRO ALFREDO C
5 patentsUS8609706B2Dec 17, 2013
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
CASTRO ALFREDO C0 citations51
US8461191B2Jun 11, 2013
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
CASTRO ALFREDO C1 citations51
US8304428B2Nov 6, 2012
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
CASTRO ALFREDO C0 citations51
US8178690B2May 15, 2012
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
CASTRO ALFREDO C0 citations51
US7745464B2Jun 29, 2010
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
CASTRO ALFREDO C0 citations51
BIOGEN IDEC INC
3 patentsBUI MINNA
2 patentsINFINITY PHARMACEUTICALS INC
2 patentsUS7851637B2Dec 14, 2010
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
INFINITY PHARMACEUTICALS INC13 citations81
US7842815B2Nov 30, 2010
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
INFINITY PHARMACEUTICALS INC5 citations61